Highlighting the absence of evidence for the controllability of AI, Dr. Yampolskiy warns of the existential risks involved and advocates for a cautious approach to AI development, with a focus on safety and risk minimization.
There is no current evidence that AI can be controlled safely, according to an extensive review, and without proof that AI can be controlled, it should not be developed, a researcher warns.
Despite the recognition that the problem of AI control may be one of the most important problems facing humanity, it remains poorly understood, poorly defined, and poorly researched, Dr. Roman V. Yampolskiy explains.
In his upcoming book, AI: Unexplainable, Unpredictable, Uncontrollable, AI Safety expert Dr. Yampolskiy looks at the ways that AI has the potential to dramatically reshape society, not always to our advantage.
He explains: “We are facing an almost guaranteed event with the potential to cause an existential catastrophe. No wonder many consider this to be the most important problem humanity has ever faced. The outcome could be prosperity or extinction, and the fate of the universe hangs in the balance.”
Uncontrollable superintelligence
Dr. Yampolskiy has carried out an extensive review of AI scientific literature and states he has found no proof that AI can be safely controlled – and even if there are some partial controls, they would not be enough.
He explains: “Why do so many researchers assume that AI control problem is solvable? To the best of our knowledge, there is no evidence for that, no proof. Before embarking on a quest to build a controlled AI, it is important to show that the problem is solvable.
“This, combined with statistics that show the development of AI superintelligence is an almost guaranteed event, shows we should be supporting a significant AI safety effort.”
He argues our ability to produce intelligent software far outstrips our ability to control or even verify it. After a comprehensive literature review, he suggests advanced intelligent systems can never be fully controllable and so will always present a certain level of risk regardless of the benefit they provide. He believes it should be the goal of the AI community to minimize such risk while maximizing potential benefits.
What are the obstacles?
AI (and superintelligence), differ from other programs by its ability to learn new behaviors, adjust its performance, and act semi-autonomously in novel situations.
One issue with making AI ‘safe’ is that the possible decisions and failures by a superintelligent being as it becomes more capable is infinite, so there are an infinite number of safety issues. Simply predicting the issues not be possible and mitigating against them in security patches may not be enough.
At the same time, Yampolskiy explains, AI cannot explain what it has decided, and/or we cannot understand the explanation given as humans are not smart enough to understand the concepts implemented. If we do not understand AI’s decisions and we only have a ‘black box’, we cannot understand the problem and reduce the likelihood of future accidents.
For example, AI systems are already being tasked with making decisions in healthcare, investing, employment, banking and security, to name a few. Such systems should be able to explain how they arrived at their decisions, particularly to show that they are bias-free.
Yampolskiy explains: “If we grow accustomed to accepting AI’s answers without an explanation, essentially treating it as an Oracle system, we would not be able to tell if it begins providing wrong or manipulative answers.”
Controlling the uncontrollable
As the capability of AI increases, its autonomy also increases but our control over it decreases, Yampolskiy explains, and increased autonomy is synonymous with decreased safety.
For example, for superintelligence to avoid acquiring inaccurate knowledge and remove all bias from its programmers, it could ignore all such knowledge and rediscover/proof everything from scratch, but that would also remove any pro-human bias.
“Less intelligent agents (people) can’t permanently control more intelligent agents (ASIs). This is not because we may fail to find a safe design for superintelligence in the vast space of all possible designs, it is because no such design is possible, it doesn’t exist. Superintelligence is not rebelling, it is uncontrollable to begin with,” he explains.
“Humanity is facing a choice, do we become like babies, taken care of but not in control or do we reject having a helpful guardian but remain in charge and free.”
He suggests that an equilibrium point could be found at which we sacrifice some capability in return for some control, at the cost of providing system with a certain degree of autonomy.
Aligning human values
One control suggestion is to design a machine that precisely follows human orders, but Yampolskiy points out the potential for conflicting orders, misinterpretation or malicious use.
He explains: “Humans in control can result in contradictory or explicitly malevolent orders, while AI in control means that humans are not.”
If AI acted more as an advisor it could bypass issues with misinterpretation of direct orders and potential for malevolent orders, but the author argues for AI to be a useful advisor it must have its own superior values.
“Most AI safety researchers are looking for a way to align future superintelligence to the values of humanity. Value-aligned AI will be biased by definition, pro-human bias, good or bad is still a bias. The paradox of value-aligned AI is that a person explicitly ordering an AI system to do something may get a “no” while the system tries to do what the person actually wants. Humanity is either protected or respected, but not both,” he explains.
Minimizing risk
To minimize the risk of AI, he says it needs it to be modifiable with ‘undo’ options, limitable, transparent, and easy to understand in human language.
He suggests all AI should be categorized as controllable or uncontrollable, and nothing should be taken off the table and limited moratoriums, and even partial bans on certain types of AI technology should be considered.
Instead of being discouraged, he says: “Rather it is a reason, for more people, to dig deeper and to increase effort, and funding for AI Safety and Security research. We may not ever get to 100% safe AI, but we can make AI safer in proportion to our efforts, which is a lot better than doing nothing. We need to use this opportunity wisely.”
News
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]















